Ода куркумину: сто механизмов эффективности куркумина против патологических состояний человека

В настоящее время накоплено большое количество экспериментальных данных, которые подтверждают, что основной компонент куркумы – куркумин – обладает высокой биологической активностью и широким спектром действия. Куркумин применяют в практике клинической медицины в качестве эффективного противовоспалительного, антиоксидантного, нейропротекторного, детоксицирующего и антисептического средства. На основании многочисленных обзоров клинических исследований представляется возможным применение этой биологически активной субстанции в терапии в качестве универсального средства для профилактики развития и комплексного лечения многих патологических состояний.

1. Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol. Adv. 2014 Nov 1;32(6):1053–64. doi: 10.1016/j.biotechadv.2014.04.004

2. Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The Essential Medicinal Chemistry of Curcumin. J. Med. Chem. 2017 Mar 9;60(5):1620–1637. doi: 10.1021/acs.jmedchem.6b00975

3. Капустин М. А., Чубарова А. С., Цыганков В. Г., Курченко В. П. Выделение куркуминоидов из коневища Сurcuma longa L и исследование состава полученного препарата с использованием хроматографических методов анализа // Труды Белорусского государственного университета.– 2016.– Т. 11, ч. 2.– С. 248–262. http://www.bio.bsu.by/proceedings/en/?act=7&id=542

4. Gavrilin M. V., Orlovskaya T. V., Senchenko S. P. Contents of curcuminoids in turmeric (Curcuma longa) rhizomes. Pharmacy. 2010;3:30–32 (in Russ.).

5. Goldina I. A., Gaidul K. V. Biological activity and therapeutic properties of Curcuma Longa L. Vestnik of Novosibirsk State University. 2015;131(1):141–149 (in Russ.).

6. Leung’s Encyclopedia of Common Natural Ingredients: Used in Food, Drugs and Cosmetics 3rd Edition. Wiley; 3rd edition. November 23, 2009, 810 p.

7. Wang Y, Tang Q, Duan P, Yang L. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol Immunotoxicol. 2018 Dec;40(6):476–482. doi: 10.1080/08923973.2018.1469145

8. Tabrizi R, Vakili S, Akbari M, Mirhosseini N, Lankarani KB, Rahimi M, Mobini M, Jafarnejad S, Vahedpoor Z, Asemi Z. The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytother. Res. 2019 Feb;33(2):253–262. doi: 10.1002/ptr.6226

9. Derosa G, Maffioli P, Simental-Mendía LE, Bo S, Sahebkar A. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 2016 Sep;111:394–404. doi: 10.1016/j.phrs.2016.07.004.

10. White CM, Pasupuleti V, Roman YM, Li Y, Hernandez AV. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 2019 Aug;146:104280. doi: 10.1016/j.phrs.2019.104280

11. Zam W. Gut Microbiota as a Prospective Therapeutic Target for Curcumin: A Review of Mutual Influence. J. Nutr. Metab. 2018 Dec 16;2018:1367984. doi: 10.1155/2018/1367984

12. Suhett LG, de Miranda Monteiro Santos R, Silveira BKS, Leal ACG, de Brito ADM, de Novaes JF, Lucia CMD. Effects of curcumin supplementation on sport and physical exercise: a systematic review. Crit. Rev. Food. Sci. Nutr. 2021;61(6):946–958. doi: 10.1080/10408398.2020.1749025

13. Amalraj A, Varma K, Jacob J, Divya C, Kunnumakkara AB, Stohs SJ, Gopi S. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study. J. Med. Food. 2017 Oct;20(10):1022–1030. doi: 10.1089/jmf.2017.3930.

14. Jacob J, Amalraj A, Raj KKJ, Divya C, Kunnumakkara AB, Gopi S. A novel bioavailable hydrogenated curcuminoids formulation (CuroWhite™) improves symptoms and diagnostic indicators in rheumatoid arthritis patients – A randomized, double blind and placebo controlled study. J Tradit Complement Med. 2018 Oct 10;9(4):346–352. doi: 10.1016/j.jtcme.2018.06.001

15. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. 2012 Nov;26(11):1719–25. doi: 10.1002/ptr.4639

16. Javadi M, Khadem Haghighian H, Goodarzy S, Abbasi M, Nassiri-Asl M. Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double-blind, controlled trial. Int. J. Rheum. Dis. 2019 Oct;22(10):1857–1862. doi: 10.1111/1756–185X.13688

17. Onakpoya IJ, Spencer EA, Perera R, Heneghan CJ. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. Int. J. Rheum. Dis. 2017 Apr;20(4):420–433. doi: 10.1111/1756–185X.13069

18. Bannuru RR, Osani MC, Al-Eid F, Wang C. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Semin. Arthritis. Rheum. 2018 Dec;48(3):416–429. doi: 10.1016/j.semarthrit.2018.03.001

19. Wu J, Lv M, Zhou Y. Efficacy and side effect of curcumin for the treatment of osteoarthritis: A meta-analysis of randomized controlled trials. Pak J Pharm Sci. 2019 Jan;32(1):43–51. PMID: 30772789

20. Zoi V, Galani V, Tsekeris P, Kyritsis AP, Alexiou GA. Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers. Biomedicines. 2022 Jan 28;10(2):312. doi: 10.3390/biomedicines10020312

21. Choi YH, Han DH, Kim SW, Kim MJ, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY. A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation. Prostate. 2019 May;79(6):614–621. doi: 10.1002/pros.23766

22. Delavarian Z, Pakfetrat A, Ghazi A, Jaafari MR, Homaei Shandiz F, Dalirsani Z, Mohammadpour AH, Rahimi HR. Oral administration of nanomicelle curcumin in the prevention of radiotherapy-induced mucositis in head and neck cancers. Spec. Care Dentist. 2019 Mar;39(2):166–172. doi: 10.1111/scd.12358

23. Pinheiro SL, Bonadiman AC, Borges Lemos ALDA, Annicchino BM, Segatti B, Pucca DS, Dutra PT, de Carvalho E Silva RM, Leal F. Photobiomodulation Therapy in Cancer Patients with Mucositis: A Clinical Evaluation. Photobiomodul Photomed Laser Surg. 2019 Mar;37(3):142–150. doi: 10.1089/photob.2018.4526

24. Lanjekar AB, Bhowate RR, Bakhle S, Narayane A, Pawar V, Gandagule R. Comparison of Efficacy of Topical Curcumin Gel with Triamcinolone-hyaluronidase Gel Individually and in Combination in the Treatment of Oral Submucous Fibrosis. J. Contemp. Dent. Pract. 2020 Jan 1;21(1):83–90. PMID: 32381807.

25. Ryan Wolf J, Gewandter JS, Bautista J, Heckler CE, Strasser J, Dyk P, Anderson T, Gross H, Speer T, Dolohanty L, Bylund K, Pentland AP, Morrow GR. Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial. Support Care Cancer. 2020 Jul;28(7):3303–3311. doi: 10.1007/s00520–019–05166–5

26. Vollono L, Falconi M, Gaziano R, Iacovelli F, Dika E, Terracciano C, Bianchi L, Campione E. Potential of Curcumin in Skin Disorders. Nutrients. 2019 Sep 10;11(9):2169. doi: 10.3390/nu11092169

27. Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J. Psychopharmacol. 2015 May;29(5):642–51. doi: 10.1177/0269881114552744

28. Cox KHM, White DJ, Pipingas A, Poorun K, Scholey A. Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study. Nutrients. 2020 Jun 4;12(6):1678. doi: 10.3390/nu12061678

29. Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J. Affect. Disord. 2014;167:368–75. doi: 10.1016/j.jad.2014.06.001

30. Al-Karawi D, Al Mamoori DA, Tayyar Y. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials. Phytother. Res. 2016 Feb;30(2):175–83. doi: 10.1002/ptr.5524

31. Yu JJ, Pei LB, Zhang Y, Wen ZY, Yang JL. Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. J. Clin. Psychopharmacol. 2015 Aug;35(4):406–10. doi: 10.1097/JCP.0000000000000352

32. Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, Martinez J, Wong KP, Liu J, Merrill DA, Chen ST, Henning SM, Satyamurthy N, Huang SC, Heber D, Barrio JR. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. Am. J. Geriatr. Psychiatry. 2018 Mar;26(3):266–277. doi: 10.1016/j.jagp.2017

33. Voulgaropoulou SD, van Amelsvoort TAMJ, Prickaerts J, Vingerhoets C. The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies. Brain. Res. 2019 Dec 15;1725:146476. doi: 10.1016/j.brainres.2019.146476

34. Tiekou Lorinczova H, Fitzsimons O, Mursaleen L, Renshaw D, Begum G, Zariwala MG. Co-Administration of Iron and a Bioavailable Curcumin Supplement Increases Serum BDNF Levels in Healthy Adults. Antioxidants (Basel). 2020 Jul 22;9(8):645. doi: 10.3390/antiox9080645

35. Wynn JK, Green MF, Hellemann G, Karunaratne K, Davis MC, Marder SR. The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study. Schizophr. Res. 2018 May;195:572–573. doi: 10.1016/j.schres.2017.09.046

36. Kucukgoncu S, Guloksuz S, Tek C. Effects of Curcumin on Cognitive Functioning and Inflammatory State in Schizophrenia: A Double-Blind, Placebo-Controlled Pilot Trial. J. Clin. Psychopharmacol. 2019 Mar/Apr;39(2):182–184. doi: 10.1097/JCP.0000000000001012

37. Miodownik C, Lerner V, Kudkaeva N, Lerner PP, Pashinian A, Bersudsky Y, Eliyahu R, Kreinin A, Bergman J. Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study. Clin. Neuropharmacol. 2019 Jul/Aug;42(4):117–122. doi: 10.1097/WNF.0000000000000344

38. Rezaie S, Askari G, Khorvash F, Tarrahi MJ, Amani R. Effects of Curcumin Supplementation on Clinical Features and Inflammation, in Migraine Patients: A Double-Blind Controlled, Placebo Randomized Clinical Trial. Int J. Prev. Med. 2021 Dec 1;12:161. doi: 10.4103/ijpvm.IJPVM_405_20

39. Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C. Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea. Molecules. 2018 Oct 26;23(11):2778. doi: 10.3390/molecules23112778

40. Kishimoto A, Imaizumi A, Wada H, Yamakage H, Satoh-Asahara N, Hashimoto T, Hasegawa K. Newly Developed Highly Bioavailable Curcumin Formulation, curcuRougeTM, Reduces Neutrophil/Lymphocyte Ratio in the Elderly: A Double-Blind, Placebo-Controlled Clinical Trial. J. Nutr. Sci. Vitaminol (Tokyo). 2021;67(4):249–252. doi: 10.3177/jnsv.67.249

41. Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed. Res. Int. 2014;2014:186864. doi: 10.1155/2014/186864

42. Teow SY, Liew K, Ali SA, Khoo AS, Peh SC. Antibacterial Action of Curcumin against Staphylococcus aureus: A Brief Review. J. Trop. Med. 2016;2016:2853045. doi: 10.1155/2016/2853045

43. Ferreira LLC, Abreu MP, Costa CB, Leda PO, Behrens MD, Dos Santos EP. Curcumin and Its Analogs as a Therapeutic Strategy in Infections Caused by RNA Genome Viruses. Food Environ Virol. 2022 Jun;14(2):120–137. doi: 10.1007/s12560–022–09514–3

44. Soni VK, Mehta A, Ratre YK, Tiwari AK, Amit A, Singh RP, Sonkar SC, Chaturvedi N, Shukla D, Vishvakarma NK. Curcumin, a traditional spice component, can hold the promise against COVID-19? Eur. J. Pharmacol. 2020 Nov 5;886:173551. doi: 10.1016/j.ejphar.2020.173551

45. Qin S, Huang L, Gong J, Shen S, Huang J, Tang Y, Ren H, Hu H. Meta-analysis of randomized controlled trials of 4 weeks or longer suggest that curcumin may afford some protection against oxidative stress. Nutr. Res. 2018 Dec;60:1–12. doi: 10.1016/j.nutres.2018.08.003

46. Hallajzadeh J, Milajerdi A, Kolahdooz F, Amirani E, Mirzaei H, Asemi Z. The effects of curcumin supplementation on endothelial function: A systematic review and meta-analysis of randomized controlled trials. Phytother. Res. 2019 Nov;33(11):2989–2995. doi: 10.1002/ptr.6477

47. Srinivasan A, Selvarajan S, Kamalanathan S, Kadhiravan T, Prasanna Lakshmi NC, Adithan S. Effect of Curcuma longa on vascular function in native Tamilians with type 2 diabetes mellitus: A randomized, double-blind, parallel arm, placebo-controlled trial. Phytother. Res. 2019 Jul;33(7):1898–1911. doi: 10.1002/ptr.6381

48. Osali A. Aerobic exercise and nano-curcumin supplementation improve inflammation in elderly females with metabolic syndrome. Diabetol. Metab. Syndr. 2020 Mar 30;12:26. doi: 10.1186/s13098–020–00532–4

49. Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Phytother. Res. 2019 May;33(5):1289–1301. doi: 10.1002/ptr.6323

50. Akbari M, Lankarani KB, Tabrizi R, Ghayour-Mobarhan M, Peymani P, Ferns G, Ghaderi A, Asemi Z. The Effects of Curcumin on Weight Loss Among Patients With Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Pharmacol. 2019 Jun 12;10:649. doi: 10.3389/fphar.2019.00649

51. Mousavi SM, Milajerdi A, Varkaneh HK, Gorjipour MM, Esmaillzadeh A. The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit. Rev. Food.Sci. Nutr. 2020;60(1):171–180. doi: 10.1080/10408398.2018.1517724

52. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012 Nov;35(11):2121–7. doi: 10.2337/dc12–0116

53. Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial. Complement Ther Med. 2019 Apr;43:253–260. doi: 10.1016/j.ctim.2019.02.014

54. Steigerwalt R, Nebbioso M, Appendino G, Belcaro G, Ciammaichella G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone MR, Ippolito E, Errichi BM, Ledda A, Hosoi M, Corsi M. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med. 2012 Dec;54(1 Suppl 4):11–6. PMID: 23241930.

55. Mazzolani F, Togni S, Giacomelli L, Eggenhoffner R, Franceschi F. Oral administration of a curcumin-phospholipid formulation (Meriva®) for treatment of chronic diabetic macular edema: a pilot study. Eur. Rev. Med. Pharmacol. Sci. 2018 Jun;22(11):3617–3625. doi: 10.26355/eurrev_201806_15189

56. Yang H, Xu W, Zhou Z, Liu J, Li X, Chen L, Weng J, Yu Z. Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies. Exp. Clin. Endocrinol. Diabetes. 2015 Jun;123(6):360–7. doi: 10.1055/s-0035–1545345

57. Khajehdehi P, Pakfetrat M, Javidnia K, Azad F, Malekmakan L, Nasab MH, Dehghanzadeh G. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand. J. Urol. Nephrol. 2011 Nov;45(5):365–70. doi: 10.3109/00365599.2011.585622

58. Appendino G, Belcaro G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone MR, Feragalli B, Ippolito E, Errichi BM, Pellegrini L, Ledda A, Ricci A, Bavera P, Hosoi M, Stuard S, Corsi M, Errichi S, Gizzi G. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Med. 2011 Sep;53(3 Suppl 1):43–9.

59. De Melo ISV, Dos Santos AF, Bueno NB. Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 2018 Feb;128:137–144. doi: 10.1016/j.phrs.2017.09.010

60. Hadi A, Pourmasoumi M, Ghaedi E, Sahebkar A. The effect of Curcumin/Turmeric on blood pressure modulation: A systematic review and meta-analysis. Pharmacol. Res. 2019 Dec;150:104505. doi: 10.1016/j.phrs.2019.104505

61. Cicero AFG, Sahebkar A, Fogacci F, Bove M, Giovannini M, Borghi C. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Eur. J. Nutr. 2020 Mar;59(2):477–483. doi: 10.1007/s00394–019–01916–7

62. Ebrahimkhani S, Ghavamzadeh S, Mehdizadeh A. The effects of vitamin D and curcuminoids supplementation on anthropometric measurements and blood pressure in type 2 diabetic patients with coexisting hypovitaminosis D: A double-blind, placebo-controlled randomized clinical trial. Clin. Nutr. ESPEN. 2020 Jun;37:178–186. doi: 10.1016/j.clnesp.2020.02.017

63. McClements DJ, Li F, Xiao H. The Nutraceutical Bioavailability Classification Scheme: Classifying Nutraceuticals According to Factors Limiting their Oral Bioavailability. Annu Rev. Food. Sci. Technol. 2015;6:299–327. doi: 10.1146/annurev-food-032814–014043

64. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007 Nov-Dec;4(6):807–18. doi: 10.1021/mp700113r

65. Prasad S., Tyagi A. K., Aggarwal B. B. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res. Treat. 2014;46:2–18. doi: 10.4143/crt.2014.46.1.2

66. Hassaninasab A, Hashimoto Y, Tomita-Yokotani K, Kobayashi M. Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc. Natl. Acad. Sci. USA. 2011 Apr 19;108(16):6615–20. doi: 10.1073/pnas.1016217108

67. Soloveva N. L., Sokurenkova M. S., Zypyanov O. A. Bioavailability of curcumin and methods of its enhancing. Drug development & registration. 2018;(3):46–53 (in Russ.).

68. Hou Y, Wang H, Zhang F, Sun F, Xin M, Li M, Li J, Wu X. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin. Int. J. Nanomedicine. 2019 Jan 11;14:557–571. doi: 10.2147/IJN.S191337

69. Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit. Rev. Food. Sci. Nutr. 2020;60(6):887–939. doi: 10.1080/10408398.2018.1552244

70. Improved Oral Bioavailability of Curcumin Incorporated into Micelles 2016. (ClinicalTrials.gov Identifier: NCT01982734).

71. Shi HS, Gao X, Li D, Zhang QW, Wang YS, Zheng Y, Cai LL, Zhong RM, Rui A, Li ZY, Zheng H, Chen XC, Chen LJ. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int. J. Nanomedicine. 2012;7:2601–11. doi: 10.2147/IJN.S31439

72. Jäger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparative absorption of curcumin formulations. Nut.r J. 2014 Jan 24;13:11. doi: 10.1186/1475–2891–13–11

73. Singh SP, Sharma M, Gupta PK. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells. Int. J. Biol. Macromol. 2015 Mar;74:162–70. doi: 10.1016/j.ijbiomac.2014.11.037

74. Jyoti K, Bhatia RK, Martis EAF, Coutinho EC, Jain UK, Chandra R, Madan J. Soluble curcumin amalgamated chitosan microspheres augmented drug delivery and cytotoxicity in colon cancer cells: In vitro and in vivo study. Colloids Surf B Biointerfaces. 2016 Dec 1;148:674–683. doi: 10.1016/j.colsurfb.2016.09.044

75. Shinde RL, Devarajan PV. Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion. Drug Deliv. 2017 Nov;24(1):152–161. doi: 10.1080/10717544.2016.1233593

76. Nguyen MH, Pham ND, Dong B, Nguyen TH, Bui CB, Hadinoto K. Radioprotective activity of curcumin-encapsulated liposomes against genotoxicity caused by Gamma Cobalt-60 irradiation in human blood cells. Int. J. Radiat. Biol. 2017 Nov;93(11):1267–1273. doi: 10.1080/09553002.2017.1380329

77. Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, Hosseinzadeh-Attar MJ. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. Nutr. Metab. (Lond). 2019 Jan 28;16:8. doi: 10.1186/s12986–019–0331–1

78. Jazayeri-Tehrani S.A., Rezayat S. M., Mansouri S., Qorbani M., Alavian S. M., Daneshi-Maskooni M., Hosseinzadeh-Attar M.-J. The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial. Nanomed. J. 2018;5:67–76. doi: 10.22038/NMJ.2018.005.003

79. Campbell M., Berrones A., Krishnakumar I., Charnigo R., Westgate P., Fleenor B. Responsiveness to curcumin intervention is associated with reduced aortic stiffness in young, obese men with higher initial stiffness. J. Funct. Foods. 2017;29:154–160. doi: 10.1016/j.jff.2016.12.013

80. Rahmani S., Asgary S., Askari G., Keshvari M., Hatamipour M., Feizi A., Sahebkar A. Treatment of non-alcoholic fatty liver disease with curcumin: A randomized placebo-controlled trial. Phytother. Res. 2016;30:1540–1548. doi: 10.1002/ptr.5659

81. Jazayeri-Tehrani S., Rezayat S., Mansouri S., Qorbani M., Alavian S., Daneshi-Maskooni M., Hosseinzadeh-Attar M. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): A trial protocol. BMJ Open. 2017;7: e016914. doi: 10.1136/bmjopen-2017–016914

82. Parohan M, Sarraf P, Javanbakht MH, Foroushani AR, Ranji-Burachaloo S, Djalali M. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial. Nutr. Neurosci. 2019:1–10. doi: 10.1080/1028415X.2019.1627770

83. Pridgen E., Alexis F., Farokhzad O. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin. Drug Deliv. 2015;12:1459–1473. doi: 10.1517/17425247.2015.1018175

84. Ipar V., Dsouza A., Devarajan P. Enhancing curcumin oral bioavailability through nanoformulations. Eur. J. Drug Metab. Pharmacokinet. 2019;44:459–480. doi: 10.1007/s13318–019–00545-z

85. Samuels E. R., Sevrioukova I. F. Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength. Int. J. Mol. Sci. 2021;22:852.

86. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013 Jan;15(1):195–218. doi: 10.1208/s12248–012–9432–8

87. Karomatov I. D., Atamuradova Sh. T. Antiinflammatory, antioxidant, immunomodulatory properties of the turmeric. Biology and Integrative Medicine. 2018;2:117–131. URL: https://cyberleninka.ru/article/n/protivovospalitelnye-antioksidantnye-immunomoduliruyuschie-svoystva-kurkumy (in Russ.).

88. Мусатов М. И. Общие вопросы клинического использования препаратов куркумы / М. И. Мусатов, К. В. Гайдуль // Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина. – 2015. № 2. – С. 83–91.